Illumina responds to China export ban, cuts FY2025 EPS guidance to ~$4.50

ILLUMINA, INC.

China MOFCOM prohibited Illumina from exporting sequencing instruments into China effective March 4, 2025.
FY2025 Core Illumina non-GAAP diluted EPS expected to be approximately $4.50.
Implementing incremental ~$100 million cost reduction program for FY2025 to offset China revenue impact.
CEO Jacob Thaysen reaffirms target of high-single-digit revenue growth by 2027.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.